Sumary of Common COVID-19 antibiotic flops in clinical trial: Experts weigh in:
- Findings from researchers affiliated with University of California San Francisco published in JAMA Network on July 16 analyzed 263 COVID-19 outpatients, 171 of whom were treated with a single 1.2-g oral dose of the antibiotic, while 92 patients were given a placebo.
- Glatt, the chairman of the department of medicine and chief of infectious diseases at Mount Sinai South Nassau, added: “There is no evidence that it provides any benefit to treat Covid and it should not be used unless there is an appropriate bacterial indication.
- “CDC SAYS ‘NO PLANS TO UPDATE’ SCHOOL MASK GUIDANCE AFTER PEDIATRICS GROUP BREAKS FROM WHITE HOUSEAntibiotics like azithromycin are often used to treat bacterial infections like pneumonia and sexually transmitted infections, according to Dr. Anthony J.
- “These findings do not support the routine use of azithromycin for outpatient SARS-CoV-2 infection,” Oldenburg wrote.